BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Biotech Beach

  Orexigen Therapeutics, Inc. Schedules May 9, 2012 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2012

  May 1, 2012

   · 

  1 min read
• AEterna Zentaris to Announce First Quarter 2012 Financial and Operating Results and Hold Annual Shareholders Meeting on May 9, 2012

  May 1, 2012

   · 

  1 min read
• BioMidwest

  Oncimmune LLC Release: National Jewish Health, the Nation’s Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT

  May 1, 2012

   · 

  9 min read
• Business

  C.R. Bard Names Christopher S. Holland Senior Vice President and Chief Financial Officer

  May 1, 2012

   · 

  1 min read
• Business

  QIAGEN N.V. and Cardinal Health, Inc. Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals

  May 1, 2012

   · 

  7 min read
• Biotech Beach

  Genalyte Inc. to Launch Early Access Program for Maverick™ Next-generation Multiplexing Platform at Upcoming Immunology Conferences

  May 1, 2012

   · 

  2 min read
• Business

  Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine

  May 1, 2012

   · 

  1 min read
• Biotech Beach

  Genalyte Inc. To Launch Early Access Program For Maverick(TM) Next-generation Multiplexing Platform At Upcoming Immunology Conferences

  May 1, 2012

   · 

  2 min read
• Business

  Rigel Pharmaceuticals, Inc. Announces First Quarter 2012 Financial Results

  May 1, 2012

   · 

  2 min read
• Pharm Country

  Discovery Laboratories Release: Pharmacoeconomic Analysis Shows SURFAXIN(R) May Reduce Hospital Cost Associated with Reintubation in Premature Infants

  May 1, 2012

   · 

  6 min read